GRAIL (NASDAQ:GRAL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does GRAIL (GRAL) operate in?

GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GRAIL Stock (NASDAQ: GRAL) stock price, news, charts, stock research, profile.

Open	$22.16
Close	$22.74
Volume / Avg.	1.09M / 727.00K
Day Range	$21.60 - $23.78
52 Wk Range	12.33 - 23.44
Market Cap	$764.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	-
Days to Cover	6.18

Recent News

What's Going On With Illumina Stock On Monday?

Illumina exits Nasdaq-100, reports Q3 EPS of $1.14 beating estimates, faces macroeconomic challenges, and lowers 2024 revenue guidance.

Vandana Singh

GRAIL: Biotech Stock Targeting $100B Cancer Market

GRAIL (NASDAQ:GRAL) is a small-cap biotechnology company that has gone on a very strong run over the last month and a half. Shares of the healthcare stock are up 58% since Oct. 24, as of the Dec. 11 close. The company

MarketBeat

European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine

Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million fine.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct

Nov

Buy

Hold

Sell

Strong Sell

Open	$22.16
Close	$22.74
Volume / Avg.	1.09M / 727.00K
Day Range	$21.60 - $23.78
52 Wk Range	12.33 - 23.44
Market Cap	$764.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	-
Days to Cover	6.18

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GRAIL (GRAL) stock?

You can purchase shares of GRAIL (NASDAQ:GRAL) through any online brokerage.

View our list of the best stock brokerages

Who are GRAIL (GRAL) competitors?

Other companies in GRAIL’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Altimmune (NASDAQ:ALT).

What is the forecast, or price target, for GRAIL (GRAL) stock?

GRAIL has a consensus price target of $16.00.

What is the current price for GRAIL (GRAL)?

The stock price for GRAIL (NASDAQ: GRAL) is $22.74 last updated December 16, 2024 at 4:00 PM EST.

Does GRAIL (GRAL) pay a dividend?

There are no upcoming dividends for GRAIL.

When is GRAIL (NASDAQ:GRAL) reporting earnings?

GRAIL’s Q4 earnings are confirmed for Saturday, February 15, 2025.

Is GRAIL (GRAL) going to split?

There is no upcoming split for GRAIL.

What sector and industry does GRAIL (GRAL) operate in?

GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

GRAIL

GRAIL (GRAL) Forecast